AITL
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lenalidomide in Combination With CHOP in Patients With Untreated PTCL (NCT04423926) | The First Affiliated Hospital with Nanjing Medical University | 2020-06-10 |
| CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) (NCT04021082) | Portola Pharmaceuticals | 2019-11-15 |
Track AITL automatically
Every clearance here is in the API, with alerts when new ones post.